We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

Outside China, MSD has rights to sac-TMT under the terms of a partnership signed in 2022, which involved a $17 million upfront payment and could be worth up to $1.4 billion. While the identity of ...